<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02689232</url>
  </required_header>
  <id_info>
    <org_study_id>ILBS-Variceal Bleed-001</org_study_id>
    <nct_id>NCT02689232</nct_id>
  </id_info>
  <brief_title>TEG (Thromboelastography) Based Versus Conventional Coagulation Parameters Based Correction of Coagulopathy in Non Variceal Bleed.</brief_title>
  <official_title>TEG (Thromboelastography) Based Versus Conventional Coagulation Parameters Based Correction of Coagulopathy in Non Variceal Bleed: An Open Label Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Liver and Biliary Sciences, India</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institute of Liver and Biliary Sciences, India</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      All patients with non variceal bleed who are admitted under the Department of Hepatology at
      Institute of Liver and Biliary Sciences, who meet the inclusion criteria and who provide
      informed consent.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 15, 2016</start_date>
  <completion_date type="Anticipated">February 28, 2018</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Control of bleeding for next 24 hrs in both the group.</measure>
    <time_frame>24 hours</time_frame>
    <description>Controlling of bleeding is defined as no visible bleeding and stabilization of hemoglobin and packed cell volume and haemodynamics</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>TEG (Thromboelastography) abnormalities in patients with coagulopathy related bleeding,</measure>
    <time_frame>24 hours</time_frame>
    <description>TEG (Thromboelastography) abnormalities defines as more than normal reaction time (4 to 8 minutes), and less than normal angle and amplitude angle (47 to 74 degree), amplitude (54 to 72 mm).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of TRALI (Transfusion associated lung injury) and TACO ( Transfusion associated circulatory overload) in both the groups.</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early mortality ( &lt;6 weeks) and late mortality (&gt; 6 weeks) in both the groups.</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The clinical utility of TEG (Thromboelastography) over standard coagulation test.</measure>
    <time_frame>24 hours</time_frame>
    <description>Clinical utility is defined as if the TEG parameters are within normal limits than no need to correct the coagulopathy despite of deranged standard coagulation test with respect to control of bleeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Control of bleeding in both the groups</measure>
    <time_frame>5 and 42 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of blood products transfused in both the groups.</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Non Variceal Bleed</condition>
  <arm_group>
    <arm_group_label>Thromboelastography (TEG) level</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Coagulation Profile</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Fresh Frozen Plasma</intervention_name>
    <arm_group_label>Thromboelastography (TEG) level</arm_group_label>
    <arm_group_label>Coagulation Profile</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Platelets Concentrate</intervention_name>
    <arm_group_label>Thromboelastography (TEG) level</arm_group_label>
    <arm_group_label>Coagulation Profile</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Cryo Precitipitate</intervention_name>
    <arm_group_label>Thromboelastography (TEG) level</arm_group_label>
    <arm_group_label>Coagulation Profile</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age more than 18

          -  All patient with Non Variceal bleed (INR&gt;1.8 and platelets&lt;50000)

          -  Hist logical or imaging proven liver cirrhosis.

        Exclusion Criteria:

          1. Variceal Bleed,

          2. Pregnancy.,

          3. Patients on anticoagulation

          4. Patients who refused to participate in the study

          5. Post EVL ulcer bleed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr Juned Ahmad, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Liver and Biliary Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dr Juned Ahmad, MD</last_name>
    <phone>011-46300000</phone>
    <email>ahmadjuned43.jk@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institute of Liver &amp; Biliary Sciences</name>
      <address>
        <city>New Delhi</city>
        <state>Delhi</state>
        <zip>110070</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Institute of liver and Biliary Sciences</name>
      <address>
        <city>New Delhi</city>
        <state>Delhi</state>
        <zip>110070</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr Juned Ahmad, MD</last_name>
      <phone>01146300000</phone>
      <email>ahmadjuned43.jk@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2016</study_first_submitted>
  <study_first_submitted_qc>February 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 23, 2016</study_first_posted>
  <last_update_submitted>February 12, 2018</last_update_submitted>
  <last_update_submitted_qc>February 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Blood Coagulation Disorders</mesh_term>
    <mesh_term>Hemostatic Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

